Ledger.Open graph →
SEC Form D · filed March 3, 2026

Aegle Therapeutics Corp

Offering
$700K
Sold
$456K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Woburn, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Evangelos Badiavas · Woburn, MADirectorShelley Hartman · Woburn, MAExec · DirectorDavid Schimel · Woburn, MADirectorScott Braunstein · Lynn, MADirectorLeon Moulder · Miromar Lakes, FLDirectorMikio Tanji · Woburn, MADirectorSteve O'Hara · San Carlos, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗